P2B-123

The Crown Princess Mary Cancer Centre Westmead (Sydney, Australia) › P2B-123

P2B-123

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
The Crown Princess Mary Cancer Centre Westmead (Sydney, Australia) · Dr. Kowalski
consented 2013-06-13

completed

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 2 diarrhoea with onset in cycle 6 (2013-10-22); assessed as not related to study drug (unlikely); resolved 2013-10-24.

moderate assessed

Grade 2 pyrexia with onset in cycle 2 (2013-08-03); assessed as not related to study drug (not related); resolved 2013-08-06.

moderate assessed

Grade 2 thrombocytopenia with onset in cycle 1 (2013-07-07); assessed as related to study drug (probable); resolved 2013-07-16.

moderate assessed

Data queries

0

No data queries. Open queries would appear here for this patient.